AUTL

1.57

6.08% 0.09

Pre-mercato: 1.58 0.01 +0.64%

Autolus Therapeutics Plc Adr (AUTL)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$1.48

Aprire:

$1.49

Volume 24 ore:

3.58M

Relative Volume:

0.93

Capitalizzazione di mercato:

$417.84M

Reddito:

Utile/perdita netta:

$-208.38M

Rapporto P/E:

-1.3083

EPS:

-1.2

Flusso di cassa netto:

$-156.57M

1 W Prestazione:

+14.60%

1M Prestazione:

+11.35%

6M Prestazione:

-24.88%

1 anno Prestazione:

-48.52%

Intervallo 1D:

$1.46

$1.61

Intervallo di 1 settimana:

$1.31

$1.61

Portata 52W:

$1.105

$3.11

Autolus Therapeutics Plc Adr Stock (AUTL) Company Profile

Nome

Autolus Therapeutics Plc Adr

Settore

Healthcare (1131)

Industria

Biotechnology (632)

Telefono

44 20 3829 6230

Indirizzo

THE MEDIAWORKS, LONDON

Dipendente

647

Cinguettio

Prossima data di guadagno

2024-12-12

Ultimi documenti SEC

AUTL's Discussions on Twitter

Confronta AUTL con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
AUTL Autolus Therapeutics Plc Adr	1.57	393.89M	0	-208.38M	-156.57M	-1.20
VRTX Vertex Pharmaceuticals Inc	457.26	117.50B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	722.83	76.06B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	464.56	62.53B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	916.31	56.75B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	205.04	44.10B	447.02M	-1.18B	-906.14M	-6.1812

Autolus Therapeutics Plc Adr Stock (AUTL) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-11-18	Aggiornamento	Goldman	Neutral → Buy
2024-11-15	Aggiornamento	Redburn Atlantic	Neutral → Buy
2023-11-09	Iniziato	Deutsche Bank	Buy
2023-03-27	Ripresa	Wells Fargo	Overweight
2023-03-17	Iniziato	Bryan Garnier	Buy
2021-06-14	Aggiornamento	Jefferies	Hold → Buy
2021-01-29	Downgrade	JP Morgan	Overweight → Neutral
2020-12-28	Ripresa	H.C. Wainwright	Buy
2020-07-31	Iniziato	JP Morgan	Overweight
2020-07-22	Iniziato	SunTrust	Buy
2020-04-22	Iniziato	Mizuho	Buy
2019-09-23	Iniziato	Needham	Buy
2019-05-17	Reiterato	H.C. Wainwright	Buy
2018-10-24	Iniziato	H.C. Wainwright	Buy

Mostra tutto

Autolus Therapeutics Plc Adr Borsa (AUTL) Ultime notizie

Dec 02, 2025

Check Out Autolus Therapeutics plc ADR (AUTL)’s Trade Data Rather Than the Analysts’ Views - Setenews

Dec 02, 2025

Cetera Investment Advisers Has $1.41 Million Position in Autolus Therapeutics PLC Sponsored ADR $AUTL - Defense World

Dec 02, 2025

Nov 25, 2025

An analyst sees good growth prospects for Autolus Therapeutics plc ADR (AUTL) - Setenews

Nov 25, 2025

Taking on analysts’ expectations and winning: EON Resources Inc (EONR) - Setenews

Nov 25, 2025

Ready to Jump After Recent Trade: BitMine Immersion Technologies Inc (BMNR) - Setenews

Nov 25, 2025

Iterum Therapeutics Plc (ITRM) Performance and Fundamentals Dashboard tells a completely different story - Setenews

Nov 25, 2025

Taking on analysts’ expectations and winning: enVVeno Medical Corporation (NVNO) - Setenews

Nov 25, 2025

Check out these key findings about Streamex Corp (STEX) - Setenews

Nov 25, 2025

This trade activity should not be overlooked: ETHZilla Corp (ETHZ) - Setenews

Nov 25, 2025

A better buy-in window may exist right now for Centessa Pharmaceuticals plc ADR (CNTA) - Setenews

Nov 25, 2025

How does Advanced Biomed Inc (ADVB) change from a tortoise to a hare? - Setenews

Nov 25, 2025

A look into Mobile health Network Solutions (MNDR)’s deeper side - Setenews

Nov 25, 2025

Traws Pharma Inc (TRAW) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews

Nov 25, 2025

Taking on analysts’ expectations and winning: Gelteq Ltd (GELS) - Setenews

Nov 25, 2025

Wall Street analysts’ outlook for Amaze Holdings Inc (AMZE) - Setenews

Nov 25, 2025

Is Autolus Therapeutics PLC (AUTL) One of the Fastest-Growing Penny Stocks to Buy Now? - Finviz

Nov 25, 2025

NICE Recommends AUCATZYL® (obecabtagene autoleucel) as a Treatment Option for Adult Patients (≥26 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)¹ - GlobeNewswire Inc.

Nov 25, 2025

Nov 24, 2025

Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World

Nov 24, 2025

Nov 21, 2025

A new trading data show Ashford Hospitality Trust Inc (AHT) is showing positive returns. - Setenews

Nov 21, 2025

Taking on analysts’ expectations and winning: Houston American Energy Corp (HUSA) - Setenews

Nov 21, 2025

Does Klotho Neurosciences Inc (KLTO) offer a good opportunity for investors? - Setenews

Nov 21, 2025

The time has not yet come to remove your chips from the table: Psyence Biomedical Ltd (PBM) - Setenews

Nov 21, 2025

Nov 20, 2025

Newsmax Inc (NMAX) can make a big difference with a little luck - Setenews

Nov 20, 2025

Check Out Dolly Varden Silver Corp (DVS)’s Trade Data Rather Than the Analysts’ Views - Setenews

Nov 20, 2025

Views of Wall Street’s Leading Experts on Viomi Technology Co Ltd ADR - Setenews

Nov 20, 2025

Nov 19, 2025

Are Smart Investors Making the Right Decision? Empery Digital Inc (EMPD) - Setenews

Nov 19, 2025

Wall Street analysts’ outlook for Picard Medical Inc (PMI) - Setenews

Nov 19, 2025

Nov 18, 2025